This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

July 27 - 29, 2021

Michael Pace, MBA
Founder & President at; former Vice President & Global Head, Market Access and Value Evidence, Pear Therapeutics


Mike Pace has carved a record of global health technology commercial growth at the intersection of biotechnology, chemical engineering, software development and value-based healthcare.

Mike formed and led the trailblazing Market Access, Health Economics and Real World Evidence team at prescription digital therapeutics (PDT)-, software as a medical device (SaMD)-pioneering Pear Therapeutics from May 2019 until March 2021. Prior to joining Pear, he was SVP Divisional Principal at ICON plc, where he led the firm’s Value Strategy Consulting practice and Pricing Market Access team of 60 consultants in the US and Europe. Mike has held chief commercial, product and business development roles with digital health companies including OM 1 and Beansprout Networks (acquired by IQVIA), as well as leading sales, marketing, training leadership development and managed markets functions during his tenure with specialty and primary care biopharmaceutical leaders EMD Serono, Allergan and Sanofi predecessor companies.

Mike’s career has been characterized by breaking molds, including leading a team that conceived and launched the hallmark biotech industry reference, EMD Serono Specialty Digest ™ in addition to pioneering the first outcomes based agreements for a specialty biologic with a health plan (Cigna)and with a PBM (Prime Therapeutics) in the United States. Subsequently, Mike has actualized many dozens of outcomes and value based payer arrangements between digital health, biopharma, payer and technology value chain stakeholders. He has been a leading innovator, global advisor, author, thought leader and trusted catalyst in the value based contracting field Mike has orchestrating market access and driven innovative go-to-market models for some of the world’s most cutting-edge technologies and novel therapeutics.

Mike earned his BSBA in Finance and Banking from the University of Missouri-Columbia and his MBA in Entrepreneurship and Marketing from the FW Olin School of Business at Babson College while also studying at London Business School, MIT Sloan School of Management, Thunderbird School of Global Management and IMD Business School in Switzerland.